ꢁꢁꢁꢂ
8ꢀ ꢀY. Shimotori et al.: Synthesis of antioxidant glycosyl hydroxybenzoates
(
m, 2H, H-2 and H-3), 5.90 (d, Jꢀ=ꢀ9.2 Hz, 1H, H-1), 6.74 (s, 1H, OH at Ph) 435 was filtered off the mixture and MTBE was then removed under
.87 (m, 2H, Ph), 7.93 (m, 2H, Ph); 1 C NMR (CDCl ): δ 20.6 (CH , OAc reduced pressure. The residue was subjected to flash chromatog-
3
6
3
3
at C-2, C-3 and C-4), 61.6 (C-5), 69.9 (C-2), 72.6 (C-3 and C-4), 92.5 (C-1), raphy (CHCl /MeOH, 9:1) to give the partially deacetylated product
3
1
15.5 (Ph) 132.6 (Ph), 164.2 (O-(C=O)-Ph), 169.6, 169.8, 170.2, (-C=O in 3a–e or 4a–e.
+
OAc at C-2, C-3 and C-4). HRMS. Calcd for C H O , [M] : m/z 396.1057;
18
20 10
found: m/z 396.1062.
2,3-Di-O-acetyl-β-D-glucopyranosyl benzoate (3a)ꢁYield 85%;
25
colorless solid; mp 136–137°C; R 0.48 (CHCl /MeOH, 10:1); [α] −54.7
f
3
D
2
,3,4-Tri-O-acetyl-β-D-xylopyranosyl protocatechuate (2c)ꢁYield (c 1.0, THF); IR: 3437 (O-H), 3069 (Ar, C-H), 1750 (C=C-C=O), 1601 (Ar,
25
−1 1
4
4%; colorless solid; mp 124–125°C; R 0.3 (hexane-AcOEt, 1:1); [α]
C=C), 1236 (C-O-C=O), 1028 (C-O-C=O) cm ; H NMR (DMSO-d ): δ 2.06
6
f
D
−
55.0 (c 1.0, THF); IR: 3367 (O-H), 2964 (C-H), 1728 (C=C-C=O), 1605 (m, 6H, CH , OAc at C-2 and C-3), 3.68 (m, Jꢀ=ꢀ9.2, 4.6, 2.3 Hz, 1H, H-4),
3
−1
1
(
Ar, C=C), 1533 (Ar, C=C), 1213 (C-O-C=O), 1052 (C-O-C=O) cm ; H 3.87 (m, 2H, H-6a, H-6b), 3.96 (m, 1H, H-3), 5.21 (t, Jꢀ=ꢀ9.2 Hz, 1H, H-5),
NMR (CDCl ): δꢀ=ꢀ2.06 (m, 9H, CH , OAc at C-2, C-3 and C-4), 3.62 (dd, 5.26 (dd, Jꢀ=ꢀ10.3 Hz and 9.2 Hz, 1H, H-2), 5.93 (d, Jꢀ=ꢀ9.2 Hz, 1H, H-1),
3
3
1
3
Jꢀ=ꢀ12.4 Hz and 8.2 Hz, 1H, H-5a), 4.22 (dd, Jꢀ=ꢀ12.4 Hz and 5.0 Hz, 1H, 7.46 (t, Jꢀ=ꢀ8.0 Hz, 2H, Ph), 7.60 (m, 1H, Ph), 8.02 (m, 2H, Ph); C NMR
H-5b), 5.04 (ddd, Jꢀ=ꢀ8.7 Hz, 8.2 Hz and 5.0 Hz, 1H, H-4), 5.21 (dd, (DMSO-d ): δ 20.6 (CH , OAc at C-2 and C-3), 61.5 (C-6), 68.9 (C-4), 70.2
6
3
Jꢀ=ꢀ8.7 Hz and 6.9 Hz, 1H, H-2), 5.30 (dd, Jꢀ=ꢀ8.7 Hz and 8.2 Hz, 1H, H-3), (C-2), 75.5 (C-3), 76.5 (C-5), 92.7 (C-1), 128.5 (Ph), 130.1 (Ph), 134.0 (Ph),
1
3
5
.89 (d, Jꢀ=ꢀ6.9 Hz, 1H, H-1), 6.91 (m, 1H, Ph), 7.56 (m, 2H, Ph); C NMR 147.6 (-C(=O)C-Ph), 164.5 (C(=O)CH=CH-), 169.5 (C=O, OAc at C-2), 171.2
+
(
CDCl ): δ 20.6 (CH , OAc at C-2, C-3 and C-4), 62.5 (C-5), 68.3 (C-4), (C=O, OAc at C-3). HRMS. Calcd for C H O , [M] : m/z 368.1107; found:
3
3
17 20 9
6
9.6 (C-2), 70.7 (C-3), 92.5 (C-1), 115.0 (Ph), 116.7 (Ph), 124.4 (Ph), 164.4 m/z 368.1125.
(
-C(=O)C-), 170.0, 170.1, 170.2 (-C=O in OAc at C-2, C-3 and C-4); HRMS:
+
m/z [M] Calcd for C H O : 412.1006; found: 412.1030.
2,3-Di-O-acetyl-β-D-glucopyranosyl
p-hydroxybenzoate
18
20 11
(
3b)ꢁYield 88%; colorless solid; mp 131–132°C; R 0.33 (CHCl /MeOH,
f
3
2
5
2
,3,4-Tri-O-acetyl-β-D-xylopyranosyl vaniloate (2d)ꢁYield 73%; 10:1); [α] −31.0 (c 1.0, THF); IR: 3379 (O-H), 3014 (Ar, C-H), 1732 (C=C-
D
2
D
5
colorless solid; mp 91–92°C; R ꢀ=ꢀ0.48 (hexane-AcOEt, 1:1); [α] −14.2 C=O), 1610 (Ar, C=C), 1517 (Ar, C=C), 1241 (C-O-C=O), 1086 (C-O-C=O)
f
−1
1
(
c 1.0, THF); IR: 3353 (O-H), 3000 (Ar, C-H), 1732 (C=C-C=O), 1595 (Ar, cm ; H NMR (DMSO-d ): δ 2.06 (m, 6H, CH , OAc at C-2 and C-3),
6 3
−1 1
C=C), 1519 (Ar, C=C), 1249 (C-O-C=O), 1054 (C-O-C=O) cm ; H NMR 3.58 (m, 3H, H-4, H-6a and H-6b), 3.70 (d, Jꢀ=ꢀ12.0 Hz, 1H, H-5), 4.99
(
CDCl ): δ 2.06 (m, 9H, CH , OAc at C-2, C-3 and C-4), 3.62 (dd, Jꢀ=ꢀ12.6 Hz (t, Jꢀ=ꢀ9.2 Hz, 1H, H-2), 5.18 (t, Jꢀ=ꢀ9.2 Hz, 1H, H-3), 5.88 (d, Jꢀ=ꢀ8.0 Hz,
3
3
13
and 8.6 Hz, 1H, H-5a), 3.95 (s, 3H, OCH at Ph), 4.22 (dd, Jꢀ=ꢀ12.6 Hz and 1H, H-1), 6.91 (d, Jꢀ=ꢀ7.4 Hz, 2H, Ph), 7.19 (d, Jꢀ=ꢀ7.4 Hz, 2H, Ph); C NMR
3
5
.2 Hz, 1H, H-5b), 5.04 (dd, Jꢀ=ꢀ8.6 Hz and 5.2 Hz, 1H, H-4), 5.23 (dd, (DMSO-d ): δ 20.6 (CH in OAc at C-2 and C-3), 55.9 (OCH at Ph), 59.8
6
3
3
Jꢀ=ꢀ8.6 Hz and 6.9 Hz, 1H, H-2), 5.30 (t, Jꢀ=ꢀ8.6 Hz, 1H, H-3), 5.90 (d, (C-5), 67.1 (C-6), 70.5 (C-2), 74.3 (C-3), 77.2 (C-4), 92.0 (C-1), 115.5 (Ph),
Jꢀ=ꢀ6.9 Hz, 1H, H-1), 6.17 (s, 1H, OH at Ph) 6.95 (d, Jꢀ=ꢀ8.0 Hz, 1H, Ph), 131.7 (Ph), 163.6 (-C=O in OAc at C-2), 169.5 (-C=O in OAc at C-3). HRMS.
1
3
+
7
.54 (d, Jꢀ=ꢀ1.7 Hz, 1H, Ph), 7.65 (dd, Jꢀ=ꢀ8.6 Hz and1.7 Hz, 1H, Ph);
C
Calcd for C H O , [M] : m/z 384.1057; found: m/z 384.1072.
17
20 10
NMR (CDCl ): δ 20.6 (CH , OAc at C-2, C-3 and C-4), 62.8 (C-5), 68.4
3
3
(
C-4), 69.5 (C-2), 70.8 (C-3), 92.6 (C-1), 112.0 (Ph), 114.3 (Ph), 124.9 (Ph),
2
,3-Di-O-acetyl-β-D-glucopyranosyl protocatechuate (3c)ꢁYield
1
64.2 (O-(C=O)-Ph), 169.4, 169.7, 169.8, (C=O, OAc at C-2, C-3 and C-4).
25
8
4%; colorless solid; mp 95–96°C; R 0.10 (CHCl /MeOH, 20:1); [α]
f
3
D
+
HRMS. Calcd for C H O , [M] : m/z 426.1162; found: m/z 426.1177.
1
9
22 11
−57.9 (c 1.0, THF); IR: 3423 (O-H), 2941 (C-H), 1733 (C=C-C=O), 1604
−
1 1
(
Ar, C=C), 1521 (Ar, C=C), 1221 (C-O-C=O), 1033 (C-O-C=O) cm ; H NMR
2
7
,3,4-Tri-O-acetyl-β-D-xylopyranosyl
syringoate
(2e)ꢁYield
(
DMSO-d ): δ 1.91 (s, 3H, CH , OAc at C-3), 2.06 (s, 6H, CH , OAc at
6
3
3
1%; colorless solid; mp 103–104°C; R ꢀ=ꢀ0.33 (hexane-AcOEt, 1:1);
f
C-2), 3.54 (m, 3H, H-4, H-6a and H-6b), 3.68 (d, Jꢀ=ꢀ12.0 Hz, 1H, H-5),
4.93 (dd, Jꢀ=ꢀ10.3 Hz and 8.6 Hz, 1H, H-2), 5.13 (m, 1H, H-3), 5.89 (d,
Jꢀ=ꢀ8.6 Hz, 1H, H-1), 6.82 (d, Jꢀ=ꢀ8.6 Hz, 1H, Ph), 7.27 (dd, Jꢀ=ꢀ2.3 Hz and
2
5
[
α] −51.8 (c 1.0, THF); IR: 3439 (O-H), 2948 (C-H), 1752 (C=C-C=O),
D
−
1
1
610 (Ar, C=C), 1515 (Ar, C=C), 1217 (C-O-C=O), 1039 (C-O-C=O) cm ;
1
H NMR (CDCl ): δ 2.06 (m, 9H, CH , OAc at C-2, C-3 and C-4), 3.60
13
3
3
8.6 Hz, 1H, Ph), 7.31 (d, Jꢀ=ꢀ2.3 Hz, 1H, Ph); C NMR (DMSO-d ): δ 20.6
6
(
(
1
dd, Jꢀ=ꢀ12.0 Hz and 8.6, Hz, 1H, H-5a), 3.94 (s, 6H, OCH at Ph), 4.21
3
(CH , OAc at C-2 and C-3), 59.9 (C-5), 67.2 (C-6), 70.6 (C-2), 74.7 (C-3),
3
dd, Jꢀ=ꢀ12.0 Hz and 5.2 Hz, 1H, H-5b), 5.06 (dd, Jꢀ=ꢀ8.6 Hz and 5.2 Hz,
7
7.3 (C-4), 91.6 (C-1), 116.4 (Ph), 118.9 (Ph), 122.2 (Ph), 145.1 (C(=O)
H, H-4), 5.27 (dd, Jꢀ=ꢀ8.6, 6.9 Hz, 1H, H-2), 5.33 (t, Jꢀ=ꢀ8.6 Hz, 1H, H-3),
C-Ph), 163.7 (C=O, OAc at C-2), 169.4 (C=O, OAc at C-3). HRMS. Calcd
1
3
5
.85 (d, Jꢀ=ꢀ6.9 Hz, 1H, H-1), 6.04 (s, 1H, OH at Ph), 7.33 (s, 2H, Ph);
C
+
for C H O , [M] : m/z 400.1005; found: m/z 400.1008.
17
20 11
NMR (CDCl ): δ 20.6 (CH , OAc at C-2, C-3 and C-4), 56.3 (OCH at Ph),
3
3
3
6
3.0 (C-5), 68.7 (C-4), 70.0 (C-2), 71.4 (C-3), 93.2 (C-1), 107.4 (Ph), 164.3
2
,3-Di-O-acetyl-β-D-glucopyranosyl vaniloate (3d)ꢁYield 89%;
25
(
O-(C=O)-Ph), 169.4, 169.8 (C=O, OAc at C-2, C-3 and C-4). HRMS. Calcd
colorless solid; mp 127–128°C; R 0.30 (CHCl /MeOH, 10:1); [α] −71.2
+
f
3
D
for C H O , [M] : m/z 456.1268; found: m/z 456.1291.
2
0
24 12
(
c 1.0, THF); IR: 3295 (O-H), 3021 (Ar, C-H), 2974 (C-H), 1752 (C=C-C=O),
−
1 1
1
608 (Ar, C=C), 1519(Ar, C=C), 1223 (C-O-C=O), 1032 (C-O-C=O) cm ; H
NMR (DMSO-d ): δ 1.93 (s, 3H, CH , OAc at C-3), 2.06 (s, 3H, CH , OAc
6
3
3
General procedure for Novozym 435-catalyzed regiose-
lective deacetylation
at C-2), 3.58 (m, 3H, H-4, H-6a and H-6b), 3.70 (d, Jꢀ=ꢀ11.5 Hz, 1H, H-5),
3
.82 (s, 6H, OCH at Ph), 4.97 (t, Jꢀ=ꢀ8.6 Hz, 1H, H-2), 5.17 (t, Jꢀ=ꢀ8.6 Hz,
3
1
H, H-3), 5.89 (d, Jꢀ=ꢀ8.6 Hz, 1H, H-1), 6.90 (d, Jꢀ=ꢀ8.6 Hz, 1H, Ph), 7.41
1
3
A solution of 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl hydroxyben- (d, Jꢀ=ꢀ1.7 Hz, 1H, Ph), 7.43 (dd, Jꢀ=ꢀ1.7 Hz and 8.6 Hz, 1H, Ph); C NMR
zoate 1a-e (1.0 mmol) or 2,3,4-tri-O-acetyl-β-D-xylopyranosyl hydroxy- (DMSO-d
): δ 20.6 (CH , OAc at C-2 and C-3), 55.5 (OCH at Ph), 59.9
3 3
6
benzoates 2a-e (1.0 mmol), MeOH (384 mg, 12.0 mmol), and Novozym (C-5), 67.2 (C-6), 70.7 (C-2), 74.5 (C-3), 77.4 (C-4), 91.9 (C-1), 115.4 (Ph),
4
2
35 (0.8 g) in tert-butyl methyl ether (MTBE, 10 mL) was stirred for 119.0 (Ph), 123.9 (Ph), 147.4 (C(=O)C-Ph), 163.6 (C=O in OAc at C-2),
+
+
4 h at 50°C. The progress of the reaction was monitored with thin 169.3 (C=O in OAc at C-3). HRMS. m/z [M] Calcd for C18
H
O
11, [M] : m/z
22
layer chromatography. Upon completion of the reaction, Novozym 414.1162; found: m/z 414.1183.
Brought to you by | University of Sydney Library
Authenticated
Download Date | 6/4/17 8:35 AM